Ypsomed Holding AG - news published 79 - readings 5.126

BACK
Ypsomed Holding AG

Ypsomed Holding AG

Ypsomed unveils growth roadmap at its Capital Markets Day, as a pure play injection specialist and mission critical part of the pharma value chain

09/29/2025 - 6:00am Ad hoc announcement pursuant to Art. 53 LR Burgdorf - Ypsomed (SIX: YPSN) is set to capture significant growth in multiple existing and emerging drug delivery markets and announces a mid-term ambition to reach total sales between CHF 0.9 and 1.1 billion and an EBIT between CHF 280 and 340 million in 2029/30 and to retain a ROCE around 20 % throughout the ...

Continue reading
29.09.2025
Ypsomed Holding AG

Ypsomed Holding AG

Ypsomed sells its diabetes care business to TecMed AG to become a pure play self-injection specialist

04/22/2025 - 7:00am Ad hoc announcement pursuant to Art. 53 LR Burgdorf - Ypsomed (SIX:YPSN) and TecMed AG (TecMed) have entered into an agreement for the sale of Ypsomed diabetes care business for up to CHF 420 million, including earn-out. TecMed is a company based in Burgdorf, controlled by Willy Michel. Ypsomed is focusing on strengthening its leading position in the market ...

Continue reading
22.04.2025